Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis

通过蛋白质组学分析开发自身免疫性葡萄膜炎和后巩膜炎的生物标志物组和药物

阅读:8
作者:Xueru Li, Jinying An, Lingzi Wu, Qingqin Tao, Hui Zhang, Xiaomin Zhang

Abstract

Autoimmune uveitis and posterior scleritis are ocular diseases caused by immune dysregulation. Their pathogenesis remains elusive, and delayed diagnosis can exacerbate vision loss. Our study analyzed proteomic profiles of 190 patients with Behcet's disease uveitis, posterior scleritis, and Vogt-Koyanagi-Harada syndrome. Bioinformatics methods revealed potential pathogenesis and biomarkers for the diseases, which were verified by enzyme-linked immunosorbent assay. The diagnostic accuracy was improved by constructing a biomarker combination. In addition, we used the Connectivity Map tool to analyze the differentially expressed proteins and identified small molecules with potential clinical applications. In this study, EMINIL1 and LYZ were identified as biomarkers for Behcet's uveitis, GSTP1 and PGLYRP1 for posterior scleritis, and APOH and STXBP1 for Vogt-Koyanagi-Harada syndrome. This study mapped the plasma proteins of these diseases, revealing potential pathogenesis and clinical applications of these biomarkers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。